NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE166341 Query DataSets for GSE166341
Status Public on Feb 09, 2021
Title Hoxa13 overexpression drives chromosomal instability and liver tumorigenesis in mice
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Background and aims: Class I Homeobox (HOX) genes are fundamental components of embryonic patterning and morphogenesis, also implicated in neoplastic transformations. Among them HOXA13, in particular, has been found to be the most overexpressed in HCC and to be associated with worse prognosis. However, no previous work has shown so far a direct causal effect between HOXA13 overexpression and liver tumorigenesis. In this study we aimed to prove the direct oncogenicity of HOXA13 in the liver and to unravel the molecular mechanisms of Hoxa13-induced liver tumorigenesis. Approach and Results:  To unravel the oncogenic mechanism of HOXA13 in vivo, a transgenic mouse model of HOXA13 overexpression in the liver was generated using hydrodynamic tail vein injection coupled with a transposase system. The mice phenotype was followed over time, from 2 weeks up to 1-year post injection. RNA-sequencing was performed to monitor the transcriptomic changes over time. HOXA13-overexpression in the liver led to highly proliferative hepatocytes and correlated with the DNA damage marker yH2AX. 1-year post-injection 50% of the injected mice developed liver tumors of various histological grades and types. RNA-sequencing analysis performed on whole liver extracts of 2 weeks-old mice and tumors showed that the main pathway deregulated by HOXA13 overexpression was cell cycle, in particular G2/M transition and mitotic spindle assembly checkpoint. Additionally, HOXA13-overexpressing livers showed a transcriptomic signature of chromosomal Instability, suggesting a possible mechanism of tumorigenesis driven by genome instability. Conclusions: Our study highlights the role of HOXA13 as a novel oncogenic driver in hepatocarcinogenesis and strongly suggests that its oncogenic properties are least partially mediated by induction of chromosomal instability.
 
Overall design Hoxa13 ChIP from HepG2 and huh7 cells, with IgG and input controls. HA ChIP from the same cell lines with HA tagged Hoxa13
 
Contributor(s) Bianco G, Gallon J, Coto-Llerena M, Kancherla V, Taha-Mehlitz S, O'Connor T, Ehmer U, Oellinger R, Montazeri H, Matter M, Christofori G, Ng CK, Piscuoglio S, Heikenwälder M, Terracciano LM
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Feb 08, 2021
Last update date Feb 09, 2021
Contact name Salvatore Piscuoglio
E-mail(s) [email protected]
Organization name University of Basel
Department Department of Biomedicine
Lab Visceral Surgery and Precision Medicine
Street address Schönbeinstrasse 40
City Basel
ZIP/Postal code 4031
Country Switzerland
 
Platforms (1)
GPL21697 NextSeq 550 (Homo sapiens)
Samples (12)
GSM5068766 Hoxa13 ChIP - HepG2 cells
GSM5068767 IgG ChIP - HepG2 cells
GSM5068768 Input - HepG2 cells
Relations
BioProject PRJNA700569
SRA SRP305300

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE166341_HepG2-Hoxa13_HepG2-input_peaks.narrowPeak.gz 1.4 Mb (ftp)(http) NARROWPEAK
GSE166341_HepG2HA-HA_HepG2HA-input_peaks.narrowPeak.gz 918.9 Kb (ftp)(http) NARROWPEAK
GSE166341_huh7-Hoxa13_huh7-input_peaks.narrowPeak.gz 214.9 Kb (ftp)(http) NARROWPEAK
GSE166341_huh7HA-HA_huh7HA-input_peaks.narrowPeak.gz 601.3 Kb (ftp)(http) NARROWPEAK
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap